Pharmaceutical Chemistry

Welcome Message

It is our great pleasure to welcome you to the 22nd International Conference on Pharmaceutical Chemistry, scheduled for June 29–30, 2026, in London, UK. This prestigious international gathering is dedicated to advancing the field under the theme “Innovations in Pharmaceutical Chemistry for Next-Generation Therapeutics.”

The conference will serve as a global platform for researchers, academicians, industry professionals, healthcare experts, and students to share their latest research findings, innovative methodologies, and emerging trends in pharmaceutical chemistry. The scientific program includes keynote lectures, plenary sessions, oral and poster presentations, workshops, and panel discussions, covering areas such as drug design and discovery, medicinal chemistry, pharmaceutical analysis, novel drug delivery systems, computational chemistry, regulatory sciences, and translational research.

This event is designed to encourage interdisciplinary collaboration, promote networking opportunities, and bridge the gap between academic research and industrial applications. Participants will gain insights into cutting-edge technologies and future directions that are shaping next-generation therapeutics.

We are confident that this conference will be an enriching experience, fostering scientific exchange, professional growth, and long-term collaborations. We look forward to welcoming you to London for two days of insightful discussions and knowledge sharing.

Warm regards,
Conference Organizing Committee

About Pharmaceutical Chemistry 2026

The 22nd International Conference on Pharmaceutical Chemistry (Pharmaceutical Chemistry 2026) is a premier scientific event bringing together global experts in pharmaceutical sciences to address the latest advancements, challenges, and opportunities in drug discovery and development. Taking place on June 29–30, 2026, in London, UK, this conference focuses on the theme “Innovations in Pharmaceutical Chemistry for Next-Generation Therapeutics.”

Pharmaceutical Chemistry is a multidisciplinary science that integrates organic chemistry, medicinal chemistry, biochemistry, analytical chemistry, and pharmacology to design, synthesize, analyze, and optimize therapeutic agents. It plays a pivotal role in transforming scientific discoveries into safe and effective medicines that improve human health.

Pharmaceutical Chemistry 2026 will highlight cutting-edge research and innovation in areas such as:

• Drug discovery and design: Novel molecular targets, lead optimization, and structure-based design

• Medicinal and computational chemistry: AI-driven approaches, cheminformatics, and predictive modeling

• Pharmaceutical analysis and quality assurance: Advanced analytical techniques and regulatory compliance

• Novel drug delivery systems: Nanotechnology, targeted delivery, and controlled release platforms

• Translational research: Bridging laboratory findings with clinical development

• Green and sustainable chemistry: Eco-friendly synthesis and sustainable practices

The conference is an excellent opportunity for scientists, academicians, researchers, healthcare professionals, and industry representatives to exchange knowledge, foster collaborations, and explore emerging trends that are shaping next-generation therapeutics. Through keynote presentations, technical sessions, workshops, and networking events, Pharmaceutical Chemistry 2026 aims to inspire innovation and excellence in pharmaceutical research worldwide.

Why Attend Pharmaceutical Chemistry 2026

• Gain insights into latest innovations and emerging trends in pharmaceutical and medicinal chemistry
• Learn from renowned international speakers and industry experts
• Explore advanced drug discovery, design, and development strategies
• Discover novel drug delivery systems and next-generation therapeutics
• Stay updated on regulatory guidelines, quality standards, and analytical advancements
• Present your research through oral or poster presentations
• Network with global researchers, academicians, and industry professionals
• Build collaborations and partnerships for future research and career growth
• Enhance your professional profile and academic visibility
• Experience a prestigious international scientific platform in London, UK

Target Audience

• Pharmaceutical Chemists
• Medicinal & Synthetic Chemists
• Drug Discovery and Lead Optimization Scientists
• Formulation Scientists and Drug Delivery Experts
• Analytical Chemists and Quality Control Professionals
• Regulatory Affairs and Compliance Specialists
• Clinical Research and Translational Scientists
• Pharmacologists and Toxicologists
• Computational Chemists and Cheminformatics Experts
• Nanotechnology and Novel Therapeutics Researchers
• Biotechnology and Life Science Professionals
• CRO, CDMO, and R&D Organization Representatives
• Pharmaceutical Manufacturing and Process Chemists
• Quality Assurance and Validation Professionals
• Patent Analysts and Intellectual Property Professionals
• Healthcare Researchers and Innovation Managers
• Academicians, Professors, and Research Supervisors
• Research Scholars, Postgraduate & PhD Students
• Startup Founders and Entrepreneurs in Pharma & Biotech
• Government, Regulatory Bodies, and Policy Makers

Sessions & Tracks

Session 01: Drug Discovery and Medicinal Chemistry

Drug discovery and medicinal chemistry are central to the development of innovative and effective therapeutic agents. This session highlights modern approaches used in identifying and validating drug targets, discovering lead compounds, and optimizing them into potential drug candidates. It covers structure–activity relationship (SAR) studies, rational and structure-based drug design, synthetic and organic chemistry strategies, and the use of computational tools and artificial intelligence to accelerate drug discovery. Emphasis is also placed on optimizing pharmacokinetic and pharmacodynamic properties, ADMET profiling, and the development of novel chemical entities and small-molecule therapeutics. The session further explores emerging trends such as targeted therapies, personalized medicine, and translational research that bridges laboratory discoveries with preclinical and clinical development.

Session 02: Pharmaceutical Analysis and Quality Assurance

Pharmaceutical analysis and quality assurance are essential for maintaining the safety, efficacy, and consistency of pharmaceutical products. This session focuses on advanced analytical techniques including HPLC, UPLC, GC, LC–MS/MS, NMR, FTIR, and UV–Visible spectroscopy, along with method development and validation as per ICH guidelines. Topics include impurity profiling, stability and degradation studies, bioanalytical method development, and quality control testing of raw materials, intermediates, and finished dosage forms. The session also addresses pharmaceutical quality systems, GMP compliance, data integrity, regulatory requirements, and emerging trends such as automation, digitalization, and real-time quality monitoring in pharmaceutical analysis.

Session 03: Novel Drug Delivery Systems and Formulation Chemistry

Novel drug delivery systems and formulation chemistry play a vital role in improving the therapeutic effectiveness, safety, and patient compliance of pharmaceutical products. This session focuses on innovative formulation strategies and advanced drug delivery technologies designed to enhance bioavailability, stability, and targeted delivery of drugs. Topics include controlled and sustained release systems, targeted and site-specific drug delivery, transdermal, buccal, nasal, pulmonary, and parenteral delivery systems, as well as advanced oral formulations. The session will also explore lipid-based carriers, nanoparticles, microspheres, liposomes, polymeric systems, and nanotechnology-driven drug delivery approaches. Emphasis is placed on formulation challenges, excipient selection, scale-up considerations, and regulatory aspects associated with novel delivery systems. This session aims to bridge formulation science with clinical performance, highlighting how innovative delivery platforms can support next-generation therapeutics.

Session 04: Computational Chemistry and AI in Drug Development

Computational chemistry and artificial intelligence are transforming pharmaceutical research by enabling faster, more cost-effective drug discovery and development. This session covers the application of molecular modeling, molecular docking, dynamics simulations, QSAR studies, and cheminformatics in drug design and optimization. It also highlights the growing role of machine learning and AI-driven algorithms in target prediction, virtual screening, lead optimization, and ADMET prediction. Participants will gain insights into data-driven decision-making, integration of computational tools with experimental research, and real-world case studies demonstrating successful AI applications in pharmaceutical chemistry. The session also discusses current limitations, ethical considerations, and future opportunities of digital technologies in drug development.

Session 05: Nanotechnology and Nanomedicine

Nanotechnology has emerged as a powerful tool in pharmaceutical chemistry, offering innovative solutions for drug delivery, diagnosis, and therapy. This session focuses on the design, synthesis, characterization, and application of nanoparticles and nanocarriers in pharmaceutical and biomedical research. Topics include polymeric nanoparticles, lipid-based nanocarriers, metallic nanoparticles, nanocrystals, and hybrid nanomaterials for therapeutic and diagnostic applications. The session also explores targeted and stimuli-responsive nanomedicine, improved bioavailability of poorly soluble drugs, reduced toxicity, and enhanced therapeutic outcomes. Discussions will cover safety, toxicity assessment, scale-up challenges, and regulatory considerations associated with nanotechnology-based pharmaceuticals, highlighting their role in next-generation therapeutics.

Session 06: Green and Sustainable Pharmaceutical Chemistry

Green and sustainable pharmaceutical chemistry focuses on environmentally friendly approaches to drug synthesis and manufacturing while maintaining product quality and efficiency. This session highlights green chemistry principles applied to pharmaceutical research, including eco-friendly solvents, renewable raw materials, waste minimization, and energy-efficient processes. Topics include plant-mediated and biogenic synthesis, sustainable process chemistry, catalytic reactions, solvent-free and microwave-assisted synthesis, and life-cycle assessment of pharmaceutical products. The session also addresses regulatory expectations, industrial adoption of green practices, and the role of sustainability in reducing environmental impact and improving cost-effectiveness in pharmaceutical manufacturing.

Session 07: Regulatory Affairs, Quality Compliance, and Intellectual Property

Regulatory affairs and intellectual property are critical components in the successful development and commercialization of pharmaceutical products. This session focuses on global regulatory frameworks, including ICH guidelines, FDA, EMA, and other international regulatory requirements. Topics include regulatory submissions, documentation strategies, clinical trial regulations, quality by design (QbD), risk management, and compliance with GMP, GLP, and GCP standards. The session also covers pharmaceutical patents, intellectual property rights, technology transfer, and strategies for protecting innovation while ensuring market access. This session provides valuable insights into navigating regulatory pathways and safeguarding pharmaceutical innovations.

Session 08: Biopharmaceuticals and Biosimilars

Biopharmaceuticals and biosimilars have revolutionized the treatment landscape by offering highly targeted, effective, and personalized therapies for a wide range of diseases, including cancer, autoimmune disorders, and rare genetic conditions. This session provides an in-depth overview of the chemical, analytical, and formulation challenges associated with biologics such as monoclonal antibodies, therapeutic proteins, peptides, vaccines, and recombinant DNA products. It covers upstream cell-line development, downstream purification processes, formulation optimization, stability enhancement, and cold-chain considerations. The session also focuses on biosimilar development, including physicochemical and biological characterization, comparability exercises, immunogenicity assessment, and clinical equivalence studies. Regulatory pathways, global approval requirements, manufacturing scalability, cost-effectiveness, and market access strategies are discussed to provide a comprehensive understanding of biopharmaceutical development and commercialization.

Session 09: Pharmacology, Toxicology, and ADMET Studies

A thorough understanding of pharmacology, toxicology, and ADMET properties is essential to ensure drug safety and therapeutic success. This session explores the principles of drug action, receptor binding, signal transduction, and dose–response relationships, along with pharmacokinetic and pharmacodynamic evaluation. It covers preclinical safety assessment, including acute and chronic toxicity, organ-specific toxicity, genotoxicity, carcinogenicity, and reproductive toxicity studies. The session also emphasizes ADMET profiling through in vitro, in vivo, and in silico models to predict absorption, distribution, metabolism, excretion, and toxicity. Advanced approaches such as biomarker-based safety evaluation, translational pharmacology, and predictive toxicology are discussed to reduce late-stage failures and improve regulatory outcomes.

Session 10: Natural Products and Herbal Drug Chemistry

Natural products and herbal medicines continue to play a significant role in drug discovery and therapeutic innovation. This session focuses on the chemical exploration of medicinal plants, marine organisms, and microbial sources for bioactive compounds. Topics include extraction and isolation techniques, chromatographic separation, spectroscopic characterization, and structure elucidation of natural molecules. The session also highlights phytochemical screening, standardization of herbal formulations, quality control, and safety evaluation to ensure consistency and efficacy. Integration of traditional medicine systems with modern pharmaceutical chemistry, development of herbal-based formulations, regulatory challenges, and intellectual property considerations are discussed. This session aims to promote scientific validation and global acceptance of natural product-based therapeutics.

Session 11: Clinical Research and Translational Pharmaceutical Chemistry

Clinical research and translational pharmaceutical chemistry play a crucial role in converting laboratory discoveries into safe and effective medicines for patients. This session focuses on the interface between pharmaceutical chemistry, preclinical research, and clinical development. Topics include clinical trial design, bioavailability and bioequivalence studies, pharmacokinetic and pharmacodynamic evaluation in humans, and translational biomarkers. The session also addresses regulatory requirements for clinical studies, ethical considerations, patient safety, and data management. Emphasis is placed on bridging the gap between bench research and bedside application, ensuring that chemical innovations translate into meaningful clinical outcomes.

Session 12: Process Chemistry and Pharmaceutical Manufacturing

Process chemistry is essential for scaling up drug substances from laboratory synthesis to commercial manufacturing. This session focuses on the development of robust, efficient, and cost-effective synthetic routes for active pharmaceutical ingredients (APIs). Topics include process optimization, impurity control, reaction scale-up, crystallization techniques, polymorphism, and process analytical technology (PAT). The session also covers continuous manufacturing, technology transfer, and compliance with GMP standards. Discussions highlight strategies to improve yield, reduce waste, ensure product consistency, and meet global regulatory expectations in pharmaceutical manufacturing.

Session 13: Emerging Trends and Future Directions in Pharmaceutical Chemistry

The pharmaceutical industry is rapidly evolving with the integration of new technologies and innovative scientific approaches. This session explores emerging trends shaping the future of pharmaceutical chemistry, including precision medicine, advanced drug delivery platforms, AI-driven discovery, digitalization, and smart manufacturing. Topics also include novel therapeutic modalities, sustainability in drug development, regulatory science innovation, and global healthcare challenges. This session provides a forward-looking perspective, encouraging participants to explore new opportunities, adapt to evolving industry demands, and contribute to the development of next-generation therapeutics.

Session 14: Pharmaceutical Regulatory Sciences and Global Compliance

Pharmaceutical regulatory sciences are critical for ensuring that medicines meet global standards of safety, quality, and efficacy. This session focuses on international regulatory frameworks governing drug development and approval, including ICH guidelines, FDA, EMA, MHRA, and other global agencies. Topics include regulatory strategy development, dossier preparation (CTD/eCTD), lifecycle management, post-marketing surveillance, and pharmacovigilance. The session also addresses evolving regulatory expectations, data integrity, risk-based approaches, and harmonization challenges across regions. Emphasis is placed on aligning scientific innovation with regulatory compliance to accelerate market approval and ensure patient safety.

Session 15: Intellectual Property, Patents, and Technology Transfer

Intellectual property protection plays a vital role in safeguarding pharmaceutical innovation and supporting commercial success. This session focuses on patent strategy, patent drafting, filing procedures, and freedom-to-operate analysis in the pharmaceutical sector. Topics include protection of novel chemical entities, formulations, processes, and biologics, as well as patent challenges, litigation, and exclusivity strategies. The session also covers technology transfer from academia to industry, licensing models, commercialization pathways, and valuation of pharmaceutical assets. Participants will gain insights into balancing innovation, legal protection, and global market access.

Session 16: Personalized Medicine and Precision Therapeutics

Personalized medicine represents a shift toward patient-centric therapeutic approaches based on genetic, molecular, and clinical profiling. This session explores the role of pharmaceutical chemistry in developing precision therapeutics, including biomarker-driven drug design, targeted therapies, and companion diagnostics. Topics include pharmacogenomics, individualized dosing strategies, molecular diagnostics, and integration of omics technologies. The session highlights how personalized medicine improves treatment outcomes, reduces adverse effects, and supports more efficient healthcare systems, offering new opportunities for next-generation drug development.

Session 17: Pharmaceutical Innovation, Startups, and Industry

Innovation in pharmaceutical chemistry is increasingly driven by collaboration between academia, startups, and established industry players. This session focuses on innovation ecosystems, startup development, and collaborative research models that accelerate drug discovery and commercialization. Topics include funding strategies, venture capital, incubation programs, public–private partnerships, and translational research initiatives. The session also highlights success stories, challenges faced by emerging companies, and strategies for fostering sustainable innovation. Emphasis is placed on knowledge exchange, entrepreneurship, and building long-term collaborations to advance pharmaceutical science.

Session 18: Advanced Pharmaceutical Analytical Technologies

This session focuses on next-generation analytical tools and technologies that support modern pharmaceutical research and development. It covers advanced spectroscopic, chromatographic, and hyphenated techniques used for structural characterization, impurity profiling, and quality assessment of drug substances and products. Topics include real-time analytical monitoring, process analytical technology (PAT), automation, digital laboratories, and data-driven analytics. The session also highlights challenges in analyzing complex formulations, biologics, and nanomedicines, emphasizing accuracy, reproducibility, and regulatory compliance in pharmaceutical analysis.

Session 19: Drug Safety, Pharmacovigilance, and Risk Management

Drug safety monitoring is a critical aspect of pharmaceutical development and post-marketing surveillance. This session focuses on pharmacovigilance systems, adverse drug reaction reporting, signal detection, and risk management strategies. Topics include benefit–risk assessment, real-world evidence, patient safety monitoring, regulatory reporting requirements, and global safety databases. The session also explores the role of digital tools, artificial intelligence, and big data in enhancing drug safety and improving decision-making throughout the product lifecycle.

Session 20: Ethics, Sustainability, and Social Responsibility

This session addresses the ethical and social dimensions of pharmaceutical research and development. Topics include ethical considerations in drug discovery, clinical trials, data transparency, and patient consent. The session also focuses on sustainability, responsible manufacturing, environmental impact reduction, and equitable access to medicines. Discussions highlight the importance of ethical decision-making, corporate social responsibility, and sustainable innovation in shaping the future of pharmaceutical chemistry and global healthcare.

Session 21: Future Outlook and Innovations in Next-Generation Therapeutics

This concluding session provides a comprehensive outlook on future directions in pharmaceutical chemistry and therapeutic development. It focuses on breakthrough technologies, emerging therapeutic modalities, and disruptive innovations that are expected to redefine healthcare. Topics include smart therapeutics, combination therapies, digital health integration, and global innovation trends. The session encourages forward-thinking discussions, collaboration, and strategic planning to address unmet medical needs and drive the next wave of pharmaceutical advancements.

Session 22: Pharmaceutical Process Validation and Quality by Design (QbD)

This session focuses on process validation and the application of Quality by Design principles in pharmaceutical development and manufacturing. It covers risk assessment, critical quality attributes (CQAs), critical process parameters (CPPs), design of experiments (DoE), and control strategies to ensure consistent product quality. Topics include lifecycle management, continuous improvement, regulatory expectations, and integration of QbD into formulation and process development. The session highlights how systematic design approaches enhance efficiency, reduce variability, and support regulatory compliance.

Session 23: Pharmaceutical Packaging, Stability, and Shelf-Life Studies

Packaging and stability studies are essential to maintain the quality, safety, and efficacy of pharmaceutical products throughout their shelf life. This session covers primary and secondary packaging materials, container–closure systems, compatibility studies, and packaging innovations. Topics include stability testing as per ICH guidelines, degradation pathways, photostability, moisture sensitivity, and labeling requirements. The session also explores smart packaging technologies and sustainability considerations in pharmaceutical packaging.

Session 24: Artificial Intelligence, Digital Transformation, and Data Science

This session explores the growing impact of artificial intelligence, machine learning, and data science on pharmaceutical chemistry and drug development. It focuses on the use of AI-driven tools for target identification, virtual screening, molecular design, predictive ADMET modeling, and optimization of synthetic pathways. Topics include big data integration, digital laboratories, cloud-based research platforms, and automation in pharmaceutical R&D. The session also discusses challenges related to data quality, model validation, regulatory acceptance of AI-generated data, and ethical considerations. Emphasis is placed on how digital transformation is reshaping decision-making, reducing development timelines, and driving innovation across the pharmaceutical value chain.

Session 25: Global Healthcare Challenges and Pharmaceutical Solutions

This session addresses pressing global healthcare challenges and the role of pharmaceutical chemistry in developing effective, affordable, and accessible therapeutic solutions. Topics include antimicrobial resistance, emerging and re-emerging infectious diseases, chronic and lifestyle-related disorders, and unmet medical needs in developing regions. The session focuses on innovative drug discovery approaches, cost-effective formulation strategies, and scalable manufacturing solutions to improve global health outcomes. It also highlights collaborative efforts between governments, academia, industry, and international organizations to ensure equitable access to essential medicines. Discussions emphasize sustainable innovation, policy alignment, and the social impact of pharmaceutical research.

Pharmaceutical Market Analysis

The global pharmaceutical market has shown consistent and resilient growth, driven by increasing healthcare demand, an aging population, and continuous innovation in drug discovery and development. In 2022, the global pharmaceutical market was valued at approximately USD 1.5 trillion. This value increased to around USD 1.7 trillion in recent years and is projected to reach approximately USD 2.3–2.4 trillion by 2030, reflecting an estimated compound annual growth rate (CAGR) of about 6–6.5%. Major growth drivers include rising demand for specialty drugs, biologics, biosimilars, and therapies for chronic and rare diseases.

Technological advancements are significantly shaping market expansion. Increased investment in research and development, along with the adoption of artificial intelligence, data-driven drug discovery, and precision medicine, is accelerating innovation across the pharmaceutical value chain. High-growth segments such as biopharmaceuticals, oncology drugs, gene and cell therapies, and advanced drug delivery systems are expected to contribute substantially to overall market value. Improved healthcare infrastructure and wider access to medicines, particularly in developing regions, continue to strengthen global market growth.

Regionally, emerging markets are expanding at a faster pace than mature markets due to population growth, rising healthcare awareness, and supportive government initiatives. For instance, the Indian pharmaceutical market was valued at approximately USD 50 billion in 2022 and has grown to around USD 60–65 billion in recent years. It is projected to reach nearly USD 85–90 billion by 2030, growing at an estimated CAGR of 5.5–6%. Overall, the pharmaceutical industry remains well positioned for sustained long-term growth, supported by innovation, collaboration, and favorable regulatory frameworks.

Associations and societies related to pharmaceutical chemistry and pharmaceutical sciences:

• International Pharmaceutical Federation (FIP)
• American Association of Pharmaceutical Scientists (AAPS)
• American Chemical Society (ACS)
• Royal Society of Chemistry (RSC)
• European Federation for Pharmaceutical Sciences (EUFEPS)
• International Society for Pharmaceutical Engineering (ISPE)
• International Union of Pure and Applied Chemistry (IUPAC)
• Society of Pharmaceutical Education and Research (SPER)
• Indian Pharmaceutical Association (IPA)
• Association of Pharmaceutical Teachers of India (APTI)
• Indian Drug Manufacturers’ Association (IDMA)
• Organization of Pharmaceutical Producers of India (OPPI)
• Federation of Asian Pharmaceutical Associations (FAPA)
• International Society of Medicinal Chemistry (ISMC)
• Controlled Release Society (CRS)

Participation Options

Pharmaceutical Chemistry offers multiple modes of participation under the Academic / Student / Business categories. Participants may join the conference as a Delegate, Speaker, or Exhibitor, either through on-site or remote participation. Presentations can be delivered via PowerPoint, video presentation, or e-poster format, ensuring flexible and global participation.

Participation Categories

• Keynote Speaker: 45–50 minutes
• Speaker (Oral Presentation): 25–30 minutes (single presenter)
• Speaker (Workshop): 45–50 minutes (multiple presenters allowed)
• Speaker (Special Session): 45–50 minutes (multiple presenters allowed)
• Speaker (Symposium): More than 45 minutes (multiple presenters allowed)
• Delegate (Registration Only): Full access to all scientific sessions and conference benefits
• Poster Presenter: Poster presentation with full delegate benefits
• Remote Attendance: Participation via video presentation or e-poster presentation
• Exhibitor: Opportunity to showcase company products and services by booking exhibitor booths of various sizes
• Media Partner
• Sponsor
• Collaborator

Participation Benefits

• Attend keynote presentations by world-renowned researchers and experts
• Full access to all scientific and technical sessions
• Receive an official participation certificate
• Gain global recognition for your profile and research work
• Abstracts published with a unique DOI in international journals
• Up to 50% discount on full-article publication in open-access international journals
• Conference handbooks and kits
• Networking opportunities with eminent global professionals and researchers
• Learn and expand knowledge from top scientists, professionals, and industry experts
• Certified abstract publication for participation
• Build professional connections and collaborations
• Gain international exposure for your research ideas and innovations

Submit your abstract here: https://pharmaceuticalchemistry.pharmaceuticalconferences.com/abstract-submission.php
Register now: https://pharmaceuticalchemistry.pharmaceuticalconferences.com/registration.php
For inquiries:
Email: contact@speakermeeting.com
WhatsApp: +44 28 80090005

Past Conference Report

PHARMACEUTICAL CHEMISTRY 2025

The 21st International Conference on Pharmaceutical Chemistry , scheduled for November 13-14, 2025 , in Paris, France, will serve as a premier global platform for discussing the latest advancements in pharmaceutical chemistry. With the theme, "Innovative Approaches in Drug Design and Development: Shaping the Future of Pharmaceutical Chemistry", the conference aims to bring together leading scientists, researchers, industry experts, and academicians to explore groundbreaking developments in drug discovery, molecular modeling, synthetic chemistry, and pharmaceutical innovations.

PHARMACEUTICAL CHEMISTRY 2025 will cover a wide range of topics, including cutting-edge drug design techniques, advancements in medicinal chemistry, bioorganic chemistry, and innovative therapeutic approaches. Attendees can expect thought-provoking presentations, engaging discussions, and opportunities for interdisciplinary collaboration. The event will also feature workshops and poster sessions, providing an interactive environment for researchers and professionals to exchange ideas, share their findings, and explore emerging trends.

With its comprehensive agenda, the conference promises to highlight the future directions of pharmaceutical chemistry and its critical role in shaping global healthcare. By fostering collaboration between academia, industry, and regulatory bodies, PHARMACEUTICAL CHEMISTRY 2025 aims to accelerate the development of safe and effective therapeutic solutions, ensuring a brighter future for drug development and patient care.